Medical Innovation Summit – An Overview

November 03, 2017

Medical Innovation Summit – An Overview
From October 23-25, Centerline attended the 15th Annual Medical Innovation Summit hosted by Cleveland Clinic Innovations.  This year’s conference was centered around genomics, precision medicine and market-ready technologies that will advance patient care. We were exposed to many innovative technologies and were able to learn about their process into the market. In a discussion about Genomics, Advanced Imaging and the Future of Medicine, we learned about using data from advanced imaging and genomic sequencing to predict patient outcomes using their genetic code (Human Longevity Initiative).

MIS1.jpgData was a big theme at the conference this year. In the new healthcare environment, data is now used for things such as patient adherence to determine the patient’s personality traits, so the medical team can better serve the patient knowing what kind of personality they have, and if they will be a non-adhering patient (Frame Health). We also learned about a novel technology that uses eye-tracking data to monitor neural health to help assess and improve patient’s memory (Neurotrack).

We were able to learn a lot about digital health and healthcare analytics. One example being Deep 6 AI, which collects clinical trial data and helps with validation of patient selection and assists in the recruitment for clinical trials

One area of the conference that was quite close to us, since we are housed in Cleveland Clinic’s Global Cardiovascular Innovation Center (GCIC), was learning about the commercialization ecosystem and the value of partnerships in companies such as ours. 

MIS2.jpgThis session featured Cleveland Clinic Innovations, along with the GCIC. We learned about the typical pipeline of projects that relate to IOPS. We also learned about the Innovation Institute and its member systems, industry partners and strategic alliance partners. 

The key takeaway from this conference was the belief that 3D displays are the future. We learned about how some of the biggest players in the industry are investing in this new market.

Many times in surgery, surgeons ask the question, “What am I looking at?” It is our hope that IOPS can help answer this question and provide these surgeons with improved visualization and navigation during surgery.